Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MCRS1 sensitizes pancreatic cancer to T cell immunity [scRNA]

ABSTRACT: MCRS1 sensitizes pancreatic cancer to T cell immunity [scRNA]

PROVIDER: PRJNA998902 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25432373_1.fastq.gz	Fastqsanger.gz
	SRR25432373_2.fastq.gz	Fastqsanger.gz
	SRR25432374_1.fastq.gz	Fastqsanger.gz
	SRR25432374_2.fastq.gz	Fastqsanger.gz
	SRR25432375_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

MCRS1 sensitizes pancreatic cancer to T cell immunity

Project description:MCRS1 sensitizes pancreatic cancer to T cell immunity

| PRJNA998898 | ENA

MCRS1 sensitizes pancreatic cancer to T cell immunity [scRNA]

Project description:Pancreatic cancer is one of the deadliest cancers in humans and is yet refractory to immunotherapy. Identifying factors that can sensitize pancreatic cancer to immune cells may thus hold the key to improving immunotherapy efficacy. Herein, by pooled CRISPR activation screening, we find that the transcriptional regulator Mcrs1 (Microspherule protein 1) is pivotal to the immune sensitivity of pancreatic cancer cells, with elevated Mcrs1 expression inducing enhanced immune responses and tumor suppression in mice.

2024-10-14 | GSE239360 | GEO

MCRS1 sensitizes pancreatic cancer to T cell immunity [Tumor]

Project description:MCRS1 sensitizes pancreatic cancer to T cell immunity [Tumor]

| PRJNA998903 | ENA

MCRS1 sensitizes pancreatic cancer to T cell immunity [ChIP-seq]

Project description:MCRS1 sensitizes pancreatic cancer to T cell immunity [ChIP-seq]

| PRJNA998894 | ENA

MCRS1 sensitizes pancreatic cancer to T cell immunity [cellline RNA]

Project description:MCRS1 sensitizes pancreatic cancer to T cell immunity [cellline RNA]

| PRJNA998895 | ENA

MCRS1 sensitizes pancreatic cancer to T cell immunity [ATAC-seq]

Project description:MCRS1 sensitizes pancreatic cancer to T cell immunity [ATAC-seq]